News & Events > Events > Very Rare Cancer Consortium Tumor Board Meeting

Very Rare Cancer Consortium Tumor Board Meeting

Please join us for the Very Rare Cancer Consortium Tumor Board Meeting. This new initiative aims to bring cancer researchers across New York to the table to discuss compelling rare cancer cases presented by physicians and scientists from the New York Genome Center’s partner institutions. Click here to learn more about the Very Rare Cancer Consortium.

Case Conference


  • Jing Chen, MD

    Pediatric Hematology-Oncology
    Hackensack Meridian Health
    Hackensack University Medical Center

    "12 months old MLL-rearranged ALL relapse with lineage switch to AML with extensive extramedullary disease"
  • Gabriel Robbins, MD

    Assistant Professor of Pediatrics
    Hassenfeld Children’s Hospital at NYU Langone Health
    Division of Pediatric Hematology/Oncology

    "Adolescent with Ph-like B-ALL and hyperdiploidy, with overexpression of both CRLF2 and EPOR"
  • Jaclyn Rosenzweig, MD

    Pediatric Hematology-Oncology Fellow
    Memorial Sloan Kettering Cancer Center
    New York Presbyterian/Weill Cornell Medical Center

    "10 month old with FUS-ERG fusion infant B-ALL"
  • Neal Shukla, MD

    Pediatric Oncologist
    Memorial Sloan Kettering Cancer Center

    "21 year old with extramedullary relapse of mixed phenotype acute leukemia"
  • Lauren Weintraub, MD

    Director of Brain Tumor Program
    Albany Medical College

    "22 year old female isolated extramedullary AML relapse post-HSCT"
  • Maria Luisa Sulis, MD, MS

    Chief, Pediatric Hematologic
    Malignancies Service
    Memorial Sloan Kettering Cancer Center

    "Three teenagers with CML and an unusual BCR-ABL mutation of unknown significance"
Decorative image color fade left Decorative image color fade right Decorative image color fade